Vitamin C supplementation in pregnancy

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 3, 2015, Pages

  Rumbold, Alice ^a   Ota, Erika ^b   Nagata, Chie ^b   Shahrook, Sadequa ^b   Crowther, Caroline A ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; VITAMIN;

FEMALE; HEALTH CARE PLANNING; HUMAN; INTRAUTERINE GROWTH RETARDATION; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOLUTIO PLACENTAE; STILLBIRTH; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ANEMIA; DIET SUPPLEMENTATION; FETAL GROWTH RETARDATION; META ANALYSIS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

ANEMIA; ASCORBIC ACID; DIETARY SUPPLEMENTS; FEMALE; FETAL GROWTH RETARDATION; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMINS;

EID: 84961970448     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004072.pub3     Document Type: Review

References (123)

1. Beazley D, Ahokas R, Livingston J, Griggs M, Scroggs M, Sibai B. Effects of vitamin c and e supplementation on total antioxidant status (tas) and 8-isoprostane (ip) levels in women at high risk for preeclampsia [abstract]. American Journal of Obstetrics and Gynecology 2002;187(6 Pt 2):S76.
2. Beazley D, Ahokas R, Livingston J, Griggs M, Sibai BM. Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. American Journal of Obstetrics and Gynecology 2005; Vol. 192:520-1.
3. Beazley D, Livingston J, Kao L, Sibai B. Vitamin c and e supplementation in women at high risk for preeclampsia: a double-blind placebo controlled trial [abstract]. American Journal of Obstetrics and Gynecology 2002;187(6 Pt 2):S216.
4. Borna S, Borna H, Daneshbodie B. Vitamins C and E in the latency period in women with preterm premature rupture of membranes. International Journal of Gynecology & Obstetrics 2005; Vol. 90:16-20.
5. Casanueva E, Angulo ME, Goidberg S, Pfeffer F, Meza-Camacho C, Vadillo-Ortega F, et al. Bases to determine the dose of vitamin C in pregnancy [Bases para estimar las necesidades de vitamina C en la gestacion]. Gaceta Medica de Mexico 2005; Vol. 141, issue 4:273-7.
6. Casanueva E, Ripoll C, Tolentino M, Morales RM, Pfeffer F, Vilchis P, et al. Vitamin C supplementation to prevent premature rupture of the chorioamniotic membranes: a randomized trial. American Journal of Clinical Nutrition 2005; Vol. 81, issue 4:859-63.
7. Chappell L, Seed P, Briley A, Kelly F, Lee R, Hunt B, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised controlled trial. Lancet 1999;354:810-6.
8. Chappell LC, Seed PT, Kelly FJ, Briley A, Hunt BJ, Charnock-Jones DS, et al. Vitamin c and e supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. American Journal of Obstetrics and Gynecology 2002;187(3):777-84.
9. Ghomian N, Hafizi L, Takhti Z. The role of vitamin C in prevention of preterm premature rupture of membranes. Iranian Red Crescent Medical Journal 2013;15(2):113-6.
10. Gulmezoglu AM, Hofmeyr GJ, Oosthuisen MM. Placental malondialdehyde and glutathione levels in a controlled trial of antioxidant treatment in severe preeclampsia. Hypertension in Pregnancy 1996;15(3):287-95.
11. Gulmezoglu AM, Hofmeyr GJ, Oosthuisen MMJ. Antioxidants in the treatment of severe pre-eclampsia: an explanatory randomised controlled trial. British Journal of Obstetrics and Gynaecology 1997;104:689-96.
12. Gungorduk K, Asicioglu O, Gungorduk OC, Yildirim G, Besimoglu B, Ark C. Does vitamin c and vitamin e supplementation prolong the latency period before delivery following the preterm premature rupture of membranes? a randomized controlled study. American Journal of Perinatology 2014;31(3):195-202.
13. Hammar M, Berg G, Solheim F, Larsson L. Calcium and magnesium status in pregnant women. A comparison between treatment with calcium and vitamin C in pregnant women with leg cramps. International Journal of Vitamin and Nutrition Research 1987;57:179-83.
14. Hankin ME, Cellier KM. Studies of nutrition in pregnancy. V. Ascorbic acid levels of blood and milk in pregnancy and in lactation. Australian and New Zealand Journal of Obstetrics and Gynaecology 1966;6:153-60.
15. Hans U, Edward B. Regular vitamin C supplementation during pregnancy reduces hospitalization: outcomes of a Ugandan rural cohort study. Pan African Medical Journal 2010;5:15.
16. Huria A, Gupta P, Kumar D, Sharma MK. Vitamin C and vitamin E supplementation in pregnant women at risk for pre eclampsia: a randomized controlled trial. Internet Journal of Health 2010; Vol. 10, issue 2.
17. Kalpdev A, Saha SC, Dhawan V. Vitamin C and e supplementation does not reduce the risk of superimposed PE in pregnancy. Hypertension in Pregnancy 2011;30(4):447-56.
18. Kiondo P, Wamuyu-Maina G, Wandabwa J, Bimenya GS, Tumwesigye NM, Okong P. The effects of vitamin C supplementation on pre-eclampsia in Mulago Hospital, Kampala, Uganda: a randomized placebo controlled clinical trial. BMC Pregnancy and Childbirth 2014;14(1):283.
19. Holmes V, Young I, Maresh M, Pearson D, Walker J, McCance D, et al. The diabetes and pre-eclampsia intervention trial (DAPIT) [abstract]. Hypertension in Pregnancy 2004;23(Suppl 1):68.
20. Holmes VA, Young IS, Maresh MJA, Pearson DWM, Walker JD, McCance DR, et al. The diabetes and pre-eclampsia intervention trial. International Journal of Gynecology & Obstetrics 2004; Vol. 87:66-71.
21. Holmes VA, Young IS, Patterson CC, Pearson DWM, Walker JD, Maresh MJA, et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the Diabetes and Pre-Eclampsia Intervention Trial. Diabetes Care 2011;34(8):1683-8.
22. Johnston PC, Powell LA, McCance DR, Pogue K, McMaster C, Gilchrist S, et al. Placental protein tyrosine nitration and MAPK in type 1 diabetic pre-eclampsia: Impact of antioxidant vitamin supplementation. Journal of Diabetes & its Complications 2013;27(4):322-7.
23. McCance DR, Holmes VA, Maresh MJ, Patterson CC, Walker JD, Pearson DW, et al. Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial. Lancet 2010;376(9737):259-66.
24. Weissgerber TL, Gandley RE, Roberts JM, Patterson CC, Holmes VA, Young IS, et al. Haptoglobin phenotype, pre-eclampsia, and response to supplementation with vitamins C and E in pregnant women with type-1 diabetes. BJOG :an international journal of obstetrics and gynaecology 2013;120(10):1192-9.
25. McEvoy CT. Daily vitamin C in pregnant smoking women decrease wheezing in their offspring through one year of age: randomized trial and interaction with maternal nicotinic receptor ploymorphisms. Pediatric Academic Societies Annual Meeting; 2013 May 4-7; Washington DC, USA. 2013.
26. McEvoy CT. Evaluating the effects of supplemental vitamin C on infant lung function in pregnant smoking women. ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 9 April 2008) 2008.
27. McEvoy CT, Schilling D, Clay N, Jackson K, Go MD, Spitale P, et al. Vitamin C supplementation for pregnant smoking women and pulmonary function in their newborn infants: a randomized clinical trial. JAMA 2014;311(20):2074-82.
28. Nasrolahi Sh, Alimohammady Sh, Zamani M. The effect of antioxidants (vitamin E and C) on preeclampsia in primiparous women. Journal of Gorgan University of Medical Sciences 2006; Vol. 8, issue 1:17-21.
29. Ochoa-Brust GJ, Fernandez AR, Villanueva-Ruiz GJ, Velasco R, Trujillo-Hernandez B, Vasquez C. Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy. Acta Obstetricia et Gynecologica Scandinavica. 2007; Vol. 86, issue 7:783-7.
30. Duckworth S, Shennan A, Chappell L, Seed P, Briley A. Effect of antioxidant supplementation on pre-labour rupture of the membranes. Archives of Disease in Childhood: Fetal and Neonatal Edition 2011;96:Fa75-6.
31. Greenough A, Shaheen S, Shennan A, Seed P. Respiratory outcome in childhood of maternal vitamin C and E supplementation. American Journal of Respiratory and Critical Care Medicine 2009;179:A5975.
32. Greenough A, Shaheen SO, Shennan A, Seed PT, Poston L. Respiratory outcomes in early childhood following antenatal vitamin C and E supplementation. Thorax 2010;65(11):998-1003.
33. Manning L, Briley A, Poston L, Chappell L, Shennan A. Supplementation with vitamins C and E in pregnancy and liver function [abstract]. BJOG: an international journal of obstetrics and gynaecology 2007; Vol. 114, issue 8:1038.
34. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH, for the Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006; Vol. 367, issue 9517:1145-54.
35. Poston L, Shennan A, Maternal and Fetal Research Unit. Vitamins in pre-eclampsia (VIP). Maternal and Fetal Research Unit (www.mfru.info/VIP.html) (accessed 1 September 2004).
36. Shennan AH, Briley AL, Seed PT, Kelly FJ, Poston L. A randomised controlled trial (RCT) of vitamin C and E supplementation in high risk women to prevent pre-eclampsia (the vip trial; on behalf of the vip trial consortium) [abstract]. Journal of Obstetrics and Gynaecology 2006; Vol. 26, issue 1:S18-20.
37. Pressman EK, Cavanaugh JL, Mingione M, Norkus EP, Woods JR. Effects of maternal antioxidant supplementation on maternal and fetal antioxidant levels: a randomized, double-blind study. American Journal of Obstetrics and Gynecology 2003;189:1720-5.
38. Rivas-Echeverria CA, Echeverria Y, Molina L, Novoa D. Synergic use of aspirin, fish oil and vitamins C and E for the prevention of preeclampsia. Hypertension in Pregnancy 2000;19(Suppl 1):30.
39. Gandley R, Abramovici A. Prenatal vitamin C and e supplementation is associated with a reduction in placental abruption and preterm birth in smokers. Pregnancy Hypertension 2012;2(3):331-2.
40. Hauth J, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Vitamin C and E supplementation to prevent preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology 2009; Vol. 201, issue 6 Suppl 1:S175-6.
41. Hauth JC. Maternal insulin resistance and preeclampsia. American Journal of Obstetrics & Gynecology 2011;204(1 Suppl):S12.
42. Hauth JC, Clifton RG, Roberts JM, Myatt L, Spong CY, Leveno KJ, et al. Maternal insulin resistance and preeclampsia. American Journal of Obstetrics and Gynecology 2011;204(4):327.e1-6.
43. Hauth JC, Clifton RG, Roberts JM, Spong CY, Myatt L, Leveno KJ, et al. Vitamin C and E supplementation to prevent spontaneous preterm birth: a randomized controlled trial. Obstetrics & Gynecology 2010;116(3):653-8.
44. NICHD MFMU Network. Combined Antioxidants and Preeclampsia Prediction Studies. http://www.bsc.gwu.edu/mfmu/projects/capps.cgi (accessed 1 September 2004).
45. National Institute of Child Health and Human Development (NICHD). Antioxidant therapy to prevent preeclampsia. ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 14 June 2005) 2005.
46. Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. New England Journal of Medicine 2010;362(14):1282-91. [PUBMED: 20375405]
47. Roberts JM, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). A randomized controlled trial of antioxidant vitamins to prevent serious complications associated with pregnancy related hypertension in low risk, nulliparous women. American Journal of Obstetrics and Gynecology 2008; Vol. 199, issue 6 Suppl 1:S4.
48. Weissgerber T, Gandley R. Risk of types of pregnancy associated hypertension according to haptoglobin phenotype. Reproductive Sciences 2011;18(3 Suppl 1):69A.
49. Weissgerber TL, Gandley RE, McGee PL, Spong CY, Myatt L, Leveno KJ, et al. Haptoglobin phenotype, preeclampsia risk and the efficacy of vitamin C and E supplementation to prevent preeclampsia in a racially diverse population. PLoS ONE 2013;8(4):e60479.
50. Crowther CA, Dekker G, Haslam R, Robinson J. Australian Collaborative Trial of Supplements with vitamin C and vitamin E for the prevention of pre-eclampsia: a randomised controlled trial. www.adelaide.edu.au/health/og/research/mpctu.html#acts (accessed 1 September 2004).
51. Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson JS. Australian collaborative trial of supplements (ACTS) with vitamin C and E for the prevention of pre-eclampsia - a randomised controlled trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3-6; Perth, Australia. 2006:180.
52. Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson JS, for the ACTS Study Group. Vitamins C and E and the risks of preeclampsia and perinatal complications. New England Journal of Medicine 2006; Vol. 354, issue 17:1796-806.
53. Sikkema J, Franx A, Bruinse H. A double blinded randomised trial on the effect of a single dose of vitamin c on endothelium dependent vasodilatation in preeclampsia [abstract]. Hypertension in Pregnancy 2002;21(Suppl 1):46.
54. Sibai BM, Koch MA, Freire S, Pinto e Silva JL, Rudge MV, Martins-Costa S, et al. The impact of prior preeclampsia on the risk of superimposed preeclampsia and other adverse pregnancy outcomes in patients with chronic hypertension. American Journal of Obstetrics and Gynecology 2011;204(4):345.e1-6.
55. Spinnato II J, Freire S, Pinto e Silva JLP, Rudge M, Martins-Costa S, Koch M, et al. Antioxidant therapy and PROM. American Journal of Obstetrics and Gynecology 2007; Vol. 197, issue 6 Suppl 1:S196, Abstract no: 685.
56. Spinnato II JA, Freire S, Pinto e Silva JL, Rudge MV, Martins-Costa S, Koch MA, et al. Antioxidant supplementation and premature rupture of the membranes: a planned secondary analysis. American Journal of Obstetrics and Gynecology 2008; Vol. 199, issue 4:433.e1-8.
57. Spinnato JA 2nd, Freire S, Pinto E Silva JL, Cunha Rudge MV, Martins-Costa S, Koch MA, et al. Antioxidant therapy to prevent preeclampsia: a randomized controlled trial. Obstetrics and Gynecology 2007;110(6):1311-8.
58. Schoeman J, Steyn PS, Odendaal HJ, Grove D. Bacterial vaginosis diagnosed at the first antenatal visit better predicts preterm labour than diagnosis later in pregnancy. Journal of Obstetrics and Gynaecology 2005; Vol. 25, issue 8:751-3.
59. Steyn P, Odendaal H, Schoeman J, Grove D. Vitamin c, pre-eclampsia and preterm labour: a randomized, placebo-controlled, double blind trial [abstract]. Hypertension in Pregnancy 2002;21(Suppl 1):43.
60. Steyn PS, Odendaal HJ, Schoeman J, Stander C, Fanie N, Grove D. A randomised, double-blind placebo-controlled trial of ascorbic acid supplementation for the prevention of preterm labour. Journal of Obstetrics and Gynaecology 2003;23(2):150-5.
61. Villar J, Purwar M, Merialdi M, Zavaleta N, Ngoc N, Anthony J, et al. Effect of vitamin C & E supplementation of pregnant women at risk of preeclampsia plus low nutritional status: the WHO trial. Hypertension in Pregnancy 2008; Vol. 27, issue 4:501.
62. Villar J, Purwar M, Merialdi M, Zavaleta N, Thi Nhu Ngoc N, Anthony J, et al. World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries. BJOG: an international journal of obstetrics and gynaecology 2009; Vol. 116, issue 6:780-8.
63. Villar J, Purwar M, Merialdi M, Zavaleta N, Tien NN, Anthony J. WHO randomized trial of vitamin C and E supplementation among women at high risk for preeclampsia and nutritional deficiency. American Journal of Obstetrics and Gynecology 2007; Vol. 197, issue 6 Suppl 1:S4, Abstract no: 8.
64. Fraser W, Xiong X, Poston L, Shennan A. Bi-national randomized controlled trial of vitamin c and e supplementation of pregnancy [abstract]. Hypertension in Pregnancy 2002;21(Suppl 1):43.
65. Fraser WD. International trial of antioxidant for the prevention of preeclampsia. Current Controlled Trials (www.controlled-trials.com/mrct) (accessed 29 November 2005) 2005.
66. Xu H, Perez-Cuevas R, Xiong X, Reyes H, Julien P, Smith G, et al. A international trials of vitamins C and E in the prevention of preeclampsia (INTAPP trial). American Journal of Obstetrics and Gynecology 2009; Vol. 201, issue 6 Suppl 1:S2.
67. Xu H, Perez-Cuevas R, Xiong X, Reyes H, Roy C, Julien P, et al. An international trial of antioxidants in the prevention of preeclampsia (INTAPP). American Journal of Obstetrics and Gynecology 2010; Vol. 202, issue 3:239.e1-239.e10.
68. Zamani M, Goodarzi MT, Lavasani NS, Khosravi A. Effects of ascorbic acid on serum level of unconjugated estriol and its relationship with preterm premature rupture of membrane: A double-blind randomized controlled clinical trial. Iranian Journal of Medical Sciences 2013;38(3):227-32.
69. Zodzika J, Rezeberga D, Donders G, Vedmedovska N, Vasina O, Pundure I, et al. Impact of vaginal ascorbic acid on abnormal vaginal microflora. Archives of Gynecology & Obstetrics 2013;288(5):1039-44.
70. Bolisetty S, Naidoo D, Lui K, Koh TH, Watson D, Whitehall J. Antenatal supplementation of antioxidant vitamins to reduce the oxidative stress at delivery - a pilot study. Early Human Development 2002;67:47-53.
71. Clarke PA. Effect of maternal vitamin C supplementation on plasma vitamin C levels in preterm infants during the early neonatal period. Current Controlled Trials (www.controlled-trials.com/mrct) (accessed 15 September 2004) 2004.
72. Eskeland B, Malterud K, Ulvik RJ, Hunskaar S. Iron supplementation in pregnancy: is less enough?. Acta Obstetricia et Gynecologica Scandinavica 1997;76:822-8.
73. Ferruti MM, Speranza R. Use of the combination of adrenal cortex extract, pyriodoxal-5-phosphate, cyanocobalamin and asocrbic acid in the treatment of hypocorticism in pregnancy [Sulla utilita dell 'associazione di estratto corticosurrenale piridossal-5-fosfato, cianocobalamina e acido ascorbico nel trattemento degli stati di ipocorticalismo in gravidanza]. Minerva Ginecologica 1982;34(7-8):619-23.
74. Gomez G, Gomez J. Anaemia in general practice: controlled-release ferrous sulphate and vitamin C compared with ferrous sulphate BP. British Journal of Clinical Practice 1969;23(10):421-4.
75. Hosokawa K. Studies on anemia in pregnant women: therapeutic efficacy of iron monotherapy vs. combination therapy with iron and vitamin C [Nimpu Hinketsu ni Kansuru Kenkyu: Tetsuzai Tandoku Narabini Tetsuzai to Bitamin C Heiyo Ryoho no Chiryo Koka ni Tsuite]. Rinsho to Kenkyu (The Japanese Journal of Clinical and Experimental Medicine) 1989; Vol. 66, issue 10:3329-35.
76. Kuizon MD, Platon TP, Ancheta LP, Angeles JC, Nunez CB, Macapinlac MP. Iron supplementation studies among pregnant women. Southeast Asian Journal of Tropical Medicine and Public Health 1979; Vol. 10, issue 4:520-7.
77. Lekakis JP, Anastasiou EA, Papamichael CM, Stamatelopoulos KS, Dagre AG, Alevizaki MC, et al. Short-term oral ascorbic acid improves endothelium dependent vasodilation in women with a history of gestational diabetes mellitus. Diabetes Care 2000;23(9):1432-3.
78. Mathan BVI, Baker SH, Sood SK, Ramachandran K, Ramalingaswami V. WHO sponsored collaborative studies on nutritional anaemia in India. The effects of ascorbic acid and protein supplementation on the response of pregnant women to iron, pteroyglutamic acid and cyanocobalamin therapy. British Journal of Nutrition 1979;42:391-8.
79. Moldenhauer J, Guo S, Liang R, Prada J. Dietary intake levels of the antioxidants vitamin c and vitamin e are adequately achieved with standard prenatal vitamin supplementation in high risk pregnancy groups [abstract]. American Journal of Obstetrics and Gynecology 2002;187(6 Pt 2):S99.
80. Odendaal HJ, Popov I, Schoeman J, Smith M, Grove D. Preterm labour--is bacterial vaginosis involved?. South African Medical Journal 2002;92:231-4.
81. Ogunbode O, Otubo JAM, Akeredolu OO, Akintunde EA, Olatunji PO, Jolayemi ET. The effect of chemiron capsules on maternal and fetal hematologic indices, including birth weight. Current Therapeutic Research 1992;51(4):634-47.
82. Sezikawa A. Antioxidant supplementation in pregnant women with low antioxidant status. ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 21 June 2007) 2007.
83. Sneed SM, Zane C, Thomas MR. The effects of ascorbic acid, vitamin B6, vitamin B12, and folic acid supplementation on the breast milk and maternal nutritional status of low socioeconomic lactating women. American Journal of Clinical Nutrition 1981;34:1338-46.
84. Viegas OAC, Scott PH, Cole TJ, Eaton P, Needham PG, Wharton BA. Dietary protein energy supplementation of pregnant Asian mothers at Sorrento, Birmingham. II: selective during third trimester only. British Medical Journal 1982;285:592-5.
85. Viegas OAC, Scott PH, Cole TJ, Mansfield HN, Wharton P, Wharton BA. Dietary protein energy supplementation of pregnant Asian mothers at Sorrento, Birmingham. I: unselective during second and third trimesters. British Medical Journal 1982;285:589-92.
86. Wijaya-Erhardt M, Muslimatun S, Erhardt G. Effect of an educational intervention related to health and nutrition on pregnant women in the villages of Central Java Province, Indonesia. Health Education Journal 2014;73(4):370-81.
87. Wijaya-Erhardt M, Muslimatun S, Erhardt JG. Fermented soyabean and vitamin C-rich fruit: a possibility to circumvent the further decrease of iron status among iron-deficient pregnant women in Indonesia. Public Health Nutrition 2011;14(12):2185-96.
88. Abu-Saad K, Fraser D. Maternal nutrition and birth outcomes. Epidemiologic Reviews 2010;32:5-25.
89. Basaran A, Basaran M, Topatan B. Combined vitamin C and E supplementation for the prevention of preeclampsia: a systematic review and meta-analysis. Obstetrical & Gynecological Survey 2010;65(10):653-67.
90. Bendich A. Vitamin C safety in humans. In: Packer L, Fuchs K editor(s). Vitamin C in Health and Disease. New York, NY: Marcel Dekker, 1997:367-9.
91. Cochrane WA. Overnutrition in prenatal and neonatal life: a problem?. Canadian Medical Association Journal 1965;93:893-9.
92. Conde-Agudelo A, Romero R, Kusanovic JP, Hassan SS. Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: A systematic review and metaanalysis. American Journal of Obstetrics and Gynecology 2011;204(6):503.e1-12.
93. Diplock AT, Charleux JL, Crozier-Willi G, Kok FJ, Rice-Evans C, Roberfroid M, et al. Functional food science and defence against reactive oxidative species. British Journal of Nutrition 1998;80(Suppl 1):S77-S112.
94. Donati S, Baglio G, Spinelli A, Grandolfo ME. Drug use in pregnancy among Italian women. European Journal of Clinical Pharmacology 2000;56(4):323-8.
95. Henry A, Crowther C. Patterns of medication use during and prior to pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 2000;40(2):165-72.
96. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
97. Incebiyik A, Vural M, Camuzcuoglu A, Camuzcuoglu H, Hilali NG, Taskin A, et al. Comparison of tissue prolidase enzyme activity and serum oxidative stress level between pregnant women with placental abruption and those with a healthy pregnancy. Archives of Gynecology and Obstetrics 2015;291(4):805-9.
98. Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington DC: National Academy Press, 2000.
99. Lassi ZS, Salam RA, Haider BA, Bhutta ZA. Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes. Cochrane Database of Systematic Reviews 2013, Issue 3. [DOI: 10.1002/14651858.CD006896.pub2]
100. Lee PC, Ledwich JR, Smith DC. Large and small doses of ascorbic acid in the absorption of ferrous iron. Canadian Medical Association Journal 1967;97:181-4.
101. Levine M, Dhariwal KR, Welch RW, Wang Y Park JB. Determination of optimal vitamin C requirements in humans. American Journal of Clinical Nutrition 1995;62(6 Suppl):1347S-1356S.
102. Lind J. A Treatise of the Scurvy. In Three Parts. Containing an Inquiry into the Nature, Causes and Cure, of that Disease. Together With a Critical and Chronological view of what has been published on the Subject. Edinburgh: Sands, Murray and Cochran for A Kincaid and A Donaldson, 1753. In: The James Lind Library: www.jameslindlibrary.org, 1753.
103. Mathews F, Yudkin P, Neil A. Influence of maternal nutrition on outcome of pregnancy: prospective cohort study. BMJ 1999;319:339-43.
104. Myatt L, Cui X. Oxidative stress in the placenta. Histochemistry and Cell Biology 2004;122(4):369-82.
105. NHMRC . Nutrient Reference Values for Australia and New Zealand. Canberra, Australia: Commonwealth of Australia, 2006.
106. Nienhuis AW. Vitamin C and iron. New England Journal of Medicine 1981;304:170-1.
107. Packer JE, Slater TF, Willson RL. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979;278:737-8.
108. Peña-Rosas JP, De-Regil LM, Dowswell T, Viteri FE. Intermittent oral iron supplementation during pregnancy. Cochrane Database of Systematic Reviews 2012, Issue 7. [DOI: 10.1002/14651858.CD009997]
109. Peña-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database of Systematic Reviews 2015, Issue 7. [DOI: 10.1002/14651858.CD004736.pub5]
110. Read RSD. Vitamin C. In: Truswell SA, Dreosti IE, English RM, Palmer N, Rutishauser IHE editor(s). Recommended Nutrient Intakes, Australian Papers. Sydney: Australian Professional Publications, 1990.
111. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
112. Roberts JM, Hubel CA. Is oxidative stress the link in the two-stage model of pre-eclampsia?. Lancet 1999;353:788-9.
113. Rumbold AR, Crowther CA. Vitamin E supplementation in pregnancy. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD004069.pub2]
114. Rumbold A, Duley L, Crowther C, Haslam R. Antioxidants for preventing pre-eclampsia. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD004227.pub3]
115. Saugstad OD. Hypoxanthine as an indicator of hypoxia: its role in health and disease through free radical production. Pediatric Research 1988;23:143-50.
116. Saugstad OD. Update on oxygen radical disease in neonatology. Current Opinion in Obstetrics and Gynecology 2001;13(2):147-53.
117. Sharma SC, Walzman M, Bonnar J, Molloy A. Blood ascorbic acid and histamine levels in patients with placental bleeding. Human Nutrition. Clinical Nutrition 1985;39(3):233-8.
118. Sharma SC, Bonnar J, Dóstalóva L. Comparison of blood levels of vitamin A, beta-carotene and vitamin E in abruptio placentae with normal pregnancy. International Journal for Vitamin and Nutrition Research 1986;56(1):3-9.
119. Silvers KM, Gibson AT, Russell JM, Powers HJ. Antioxidant activity, packed cell transfusions, and outcome in premature infants. Archives of Disease in Childhood Fetal and Neonatal Edition 1998;78:F214-9.
120. Stokes PL, Melikian V, Leeming RL, Portman-Graham H, Blair JA, Cook WT. Folate metabolism in scurvy. American Journal of Clinical Nutrition 1975;28:126-9.
121. Streeter ML, Rosso P. Transport mechanisms for ascorbic acid in the human placenta. American Journal of Clinical Nutrition 1981;34(9):1706-11.
122. Woods JR Jr, Plessinger MA, Miller RK. Vitamins C and E: missing links in preventing preterm premature rupture of membranes?. American Journal of Obstetrics and Gynecology 2001;185(1):5-10.
123. Rumbold A, Crowther CA. Vitamin C supplementation in pregnancy. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD004072.pub2]